#itsos - Twitter Hashtag

about 1 year ago

Important #ITSOS @AATSHQ session on disparities in personalized cancer care. Key takeaways from the presenters: • Low cost polygenic risk scores can help escalate focus on high-risk patients • Medicaid expansion ↑ survival → broader coverage needed • Dual lung + breast screening may boost LCS in women, but access & geography remain barriers

DenaShehata__'s tweet photo. Important #ITSOS @AATSHQ session on disparities in personalized cancer care. Key takeaways from the presenters:
• Low cost polygenic risk scores can help escalate focus on high-risk patients
• Medicaid expansion ↑ survival → broader coverage needed
• Dual lung + breast screening may boost LCS in women, but access & geography remain barriers

0

7

1

0

1K

Elliot Servais, MD, FACS

@ElliotServaisMD

about 1 year ago

@RogerKimMD @GavittWoodard @Lydia_SoYeonKim This is an important trial. Lots to discuss. One ? is whether all of these patients needed an operation at all! 17.2% of the LND group had tumors with CTR = 0 (ie pure GGO). Do pure GGO <3cm need Tx or surveillance? Looking forward to this discussion at @AATSHQ #ITSOS meeting

ElliotServaisMD's tweet photo. @RogerKimMD @GavittWoodard @Lydia_SoYeonKim This is an important trial. Lots to discuss.

One ? is whether all of these patients needed an operation at all!
17.2% of the LND group had tumors with CTR = 0 (ie pure GGO). Do pure GGO <3cm need Tx or surveillance?

Looking forward to this discussion at @AATSHQ #ITSOS meeting https://t.co/QAwqo5lTUu

0

5

0

1

2K

Weston G. Andrews, MD @WGAndrewsMD

about 2 years ago

Great #ITSOS @AATSHQ meeting in NYC. Thank you for letting us present a poster on residual esophageal cancer. @BrianLouie4 et al. Glad to see the @MCWSurgery thoracic crew there @BrittonDonatoMD and @PaulLinsky

WGAndrewsMD's tweet photo. Great #ITSOS @AATSHQ meeting in NYC. Thank you for letting us present a poster on residual esophageal cancer. @BrianLouie4 et al.

Glad to see the @MCWSurgery thoracic crew there @BrittonDonatoMD and @PaulLinsky https://t.co/GLcysr8tTf

1

18

3

1

1K

Yota Suzuki @yosuzukimd

about 2 years ago

It was a great honor to present our data on this hot and controversial topic at plenary session AATS #ITSOS. I was thrilled to have a discussion with the giants in the field. Many thanks to the discussant, @LFerri123 .

yosuzukimd's tweet photo. It was a great honor to present our data on this hot and controversial topic at plenary session AATS #ITSOS. I was thrilled to have a discussion with the giants in the field. Many thanks to the discussant, @LFerri123 . https://t.co/vJLdTal6Ka

Elliot Servais, MD, FACS

@ElliotServaisMD

about 2 years ago

Clues the paper being discussed at the #ITSOS2024 plenary is on esophageal cancer…the giants at the mics Great discussion on role for esophagectomy in multimodal Tx for M1 disease. @AATSHQ @LFerri123

ElliotServaisMD's tweet photo. Clues the paper being discussed at the #ITSOS2024 plenary is on esophageal cancer…the giants at the mics

Great discussion on role for esophagectomy in multimodal Tx for M1 disease.
@AATSHQ @LFerri123 https://t.co/oaZYr2xjJe

0

6

0

1

3K

0

12

4

0

2K

Rajika Jindani, MD, MPH, MS @RajikaJindani

about 2 years ago

Day 1 of #ITSOS2024 kicked off with a great talk by @maraantonoff exploring how surgeons vs medical and radiation oncologists differ in their self treatment preferences- survey results find surgeons are more likely to pick surgery! #itsos #AATS

RajikaJindani's tweet photo. Day 1 of #ITSOS2024 kicked off with a great talk by @maraantonoff exploring how surgeons vs medical and radiation oncologists differ in their self treatment preferences- survey results find surgeons are more likely to pick surgery! #itsos #AATS https://t.co/sCWIp8jS4X

0

19

3

0

1K

Elliot Servais, MD, FACS

@ElliotServaisMD

about 3 years ago

Back in NYC for #ITSOS @AATSHQ Always nice to be back in the city since leaving ~10 years ago. (But I think all the Ubers should be painted yellow 🚕! It just doesn’t feel the same)

0

9

0

855

Johns Hopkins Thoracic Oncology @HopkinsThoracic

about 3 years ago

Dr. @SBroderickMD presenting latest CheckMate 816 3 year data on preoperative chemo-nivolumab for lung cancer at #itsos 2023 @AATSHQ #lcsm

HopkinsThoracic's tweet photo. Dr. @SBroderickMD presenting latest CheckMate 816 3 year data on preoperative chemo-nivolumab for lung cancer at #itsos 2023 @AATSHQ #lcsm https://t.co/YaVArlnIjw

0

6

1

0

723

Nan Ge @NanGe_MD

almost 4 years ago

First time #AATS meeting. AMAZING journey. @AATSHQ #ITSOS

0

3

0

Brian Whang, MD, FACS @BrianWhang

almost 4 years ago · Manhattan

Three generations of Jon Wee-trained surgeons @BrighamThoracic #AATS #ITSOS

0

16

2

0

Nan Ge @NanGe_MD

almost 4 years ago

Dr. Brendon Stiles presents The #AATS Consensus Document. About Neoad vs. Adjuvant, most of the members agree neo(Chemo-IO) is better. @AATSHQ #ITSOS

NanGe_MD's tweet photo. Dr. Brendon Stiles presents The #AATS Consensus Document. About Neoad vs. Adjuvant, most of the members agree neo(Chemo-IO) is better. @AATSHQ #ITSOS https://t.co/1LwYTyEyFV

0

2

0

D. Phan, MD, MPH @DPhanMD

about 4 years ago

Happy with the representation at this year’s @AATSHQ from @MontefioreSurg #itsos

0

5

1

0

Brendon Stiles @BrendonStilesMD

about 4 years ago

Jamie Chaft letting the surgeons at #ITSOS @AATSHQ know that the need for targeted therapy in the neoadjuvant setting is obvious. Great talk! The juice seems worth the squeeze! Proud that @lcrf_org is helping to sponsor the LEADER trial in this space. #lcsm

BrendonStilesMD's tweet photo. Jamie Chaft letting the surgeons at #ITSOS @AATSHQ know that the need for targeted therapy in the neoadjuvant setting is obvious. Great talk!

The juice seems worth the squeeze! Proud that @lcrf_org is helping to sponsor the LEADER trial in this space. #lcsm https://t.co/XmKHo8P4n2

0

19

3

1

0

Oliver J. Harrison, MD @TheChestSurgeon

almost 6 years ago

Such an honour to present our novel personalised therapy for patients with multiple pulmonary nodules at the #ITSOS. Great content and very well organised. Congrats @AATSHQ. @UHS_Thoracics @UHSFT @SiemensHealth @syrianexpat #lungcancer #thoracicsummit

TheChestSurgeon's tweet photo. Such an honour to present our novel personalised therapy for patients with multiple pulmonary nodules at the #ITSOS. Great content and very well organised. Congrats @AATSHQ. @UHS_Thoracics @UHSFT @SiemensHealth @syrianexpat #lungcancer #thoracicsummit https://t.co/Ota4ont1Ho

1

12

3

0

Shawn Groth @DrShawnGroth

almost 6 years ago

Great talk today by @BMBurtMD at the @AATSHQ #ITSOS on tumor biology and its implications for pulmonary metastatectomy! @BCM_Surgery @BCM_Thoracic

DrShawnGroth's tweet photo. Great talk today by @BMBurtMD at the @AATSHQ #ITSOS on tumor biology and its implications for pulmonary metastatectomy! @BCM_Surgery @BCM_Thoracic https://t.co/UuE6IbM2d4

0

29

3

0

Mobility Network @UofTMobilityNet

over 6 years ago

Congratulations to Professor Baher Abdulhai @civmin @UofTengineering - a new Fellow elected into the Canadian Academy of Engineering! #icityCATTS #ITSoS

UofTMobilityNet's tweet photo. Congratulations to Professor Baher Abdulhai @civmin @UofTengineering - a new Fellow elected into the Canadian Academy of Engineering! #icityCATTS #ITSoS https://t.co/VFaX5Gh8VI

CanadianAcademyofEng @TheCdnAcadofEng

over 6 years ago

Congrats to the fifty-two new Fellows elected into the Canadian Academy of Engineering today - https://t.co/dZd4QQerXK

1

15

1

0

9

3

0

Adecco Thailand @AdeccoThailand

over 6 years ago

💥 IT Support Outsource Service 💡 บริการจัดหา และ จัดจ้าง พนักงาน IT ที่มีความเชี่ยวชาญ สามารถเริ่มงานได้ทันที มีให้เลือกทั้งแบบรายวัน รายเดือน และเหมาแพคเกจรายปี ตามความต้องการของลูกค้าแบบครอบคลุม 👉 รายละเอียดเพิ่มเติม >> https://t.co/POcCdhnUr8 #ITSoS #ITSupport